Differences in the Surgical Outcomes of Glaucoma Surgery in Patients of African Caribbean Descent

References

• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013.
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618. doi:10.1136/bjophthalmol-2011-300539.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global data on visual impairments 2010. J Vis Impair Blind. 2012;96(5):614–618. doi:10.1136/bjophthalmol-2011-300539.
   Google Scholar
• Media WHO, Classification I. Visual impairment and blindness (Fact Sheet N°282). 2014.
   Google Scholar
• Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt JC, Martone JF, Royall RM, Witt KA, Ezrine S, et al. Racial differences in the cause-specific prevalence of blindness in East Baltimore. N Engl J Med. 1991;325(20):1412–1417. doi:10.1056/NEJM199111143252004.
   PubMed Web of Science ®Google Scholar
• Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat A, Hennis A. Incidence of open-angle glaucoma: the Barbados Eye Studies. Arch Ophthalmol. 2001;114(6):1058–1064.
   Google Scholar
• Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115(1):85–93. doi:10.1016/j.ophtha.2007.03.017.
   PubMed Web of Science ®Google Scholar
• Lukas TJ, Miao H, Chen L, Riordan SM, Li W, Crabb AM, Wise A, Du P, Lin SM, Hernandez MR. Susceptibility to glaucoma: differential comparison of the astrocyte transcriptome from glaucomatous African American and Caucasian American donors. Genome Biol. 2008;9(7):R111. doi:10.1186/gb-2008-9-7-r111.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Tielsch JM, Katz J, Sommer A. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol. 1996;122(3):355–363. doi:10.1016/S0002-9394(14)72062-8.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Barton K, Whiteside-de Vos J, Schiffman J, Bandi J, Nolan W, Herndon L, Kim H, Hay-Smith G, Tielsch JM. Prevalence of glaucoma in an urban West African population: the Tema Eye Survey. JAMA Ophthalmol. 2013;131(5):651–658. doi:10.1001/jamaophthalmol.2013.1686.
   PubMed Web of Science ®Google Scholar
• Mwanza J-C, Tulenko SE, Barton K, Herndon LW, Mathenge E, Hall A, Kim HY, Hay-Smith G, Budenz DL. Eight-year incidence of open-angle glaucoma in the Tema Eye Survey. Ophthalmology. 2019;126(3):372–380. doi:10.1016/j.ophtha.2018.10.016.
   PubMed Web of Science ®Google Scholar
• Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study: prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112(6):821–829. doi:10.1001/archopht.1994.01090180121046.
   PubMed Web of Science ®Google Scholar
• Netland PA, Robertson SM, Sullivan EK, Silver L, Bergamini MVW, Krueger S, Weiner AL, Davis AA. Response to travoprost in black and nonblack patients with open-angle glaucoma or ocular hypertension. Adv Ther. 2003;20(3):149–163. doi:10.1007/BF02850202.
   PubMed Web of Science ®Google Scholar
• Olateju SO, Ajayi AA. The lack of efficacy of topical beta-blockers, timolol and betaxolol on intraocular pressure in Nigerian healthy volunteers. Eye. 1999;13(6):758–763. doi:10.1038/eye.1999.223.
   PubMed Web of Science ®Google Scholar
• Devgan U, Yu F, Kim E, Coleman AL. Surgical undertreatment of glaucoma in black beneficiaries of Medicare. Arch Ophthalmol. 2000;118(2):253–256. doi:10.1001/archopht.118.2.253.
   PubMedGoogle Scholar
• Javitt JC, McBean AM, Nicholson GA, Babish JD, Warren JL, Krakauer H. Undertreatment of glaucoma among Black Americans. N Engl J Med. 1991;325(20):1418–1422. doi:10.1056/NEJM199111143252005.
   PubMed Web of Science ®Google Scholar
• Taubenslag KJ, Kammer JA. Outcomes disparities between Black and white populations in the surgical management of glaucoma. Semin Ophthalmol. 2016;31(4):385–393. doi:10.3109/08820538.2016.1154163.
   PubMed Web of Science ®Google Scholar
• Scott IU, Greenfield DS, Schiffman J, Nicolela MT, Rueda JC, Tsai JC, Palmberg PF. Outcomes of primary trabeculectomy with the use of adjunctive mitomycin. Arch Ophthalmol. 1998;116(3):286–291.
   PubMedGoogle Scholar
• Anand N, Mielke C, Dawda VK. Trabeculectomy outcomes in advanced glaucoma in Nigeria. Eye. 2001;15(Pt 3):274–278.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, Lee PP. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026.
   PubMed Web of Science ®Google Scholar
• Arora KS, Robin AL, Corcoran KJ, Corcoran SL, Ramulu PY. Use of various glaucoma surgeries and procedures in Medicare beneficiaries from 1994 to 2012. Ophthalmology. 2015;122(8):1615–1624. doi:10.1016/j.ophtha.2015.04.015.
   PubMed Web of Science ®Google Scholar
• Palmberg P. Determining if race should be considered within the choice of glaucoma surgery. JAMA Ophthalmol. 2018;136(10):1113–1114. doi:10.1001/jamaophthalmol.2018.2886.
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Sarkisian SR, Lubeck DM, Stiles MC, Duh Y-J, Romo EA, Giamporcaro JE, Hornbeak DM, Katz LJ, Bartlett W, et al. Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results. Ophthalmology. 2019;126(6):811–821. doi:10.1016/j.ophtha.2019.03.006.
   PubMed Web of Science ®Google Scholar
• Samuelson TW, Chang DF, Marquis R, Flowers B, Lim KS, Ahmed IIK, Jampel HD, Aung T, Crandall AS, Singh K, et al. A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study. Ophthalmology. 2019;126(1):29–37. doi:10.1016/j.ophtha.2018.05.012.
   PubMed Web of Science ®Google Scholar
• Angadi P, Rajpal S, Jones L. XEN Gel Stent outcomes in an African American population at Howard University Hospital | IOVS | ARVO journals. Invest Ophthalmol Vis Sci. 2019;60:3734.
   Web of Science ®Google Scholar
• Laroche D, Nkrumah G, Ng C. Real-world retrospective consecutive study of ab interno XEN 45 Gel Stent implant with mitomycin C in Black and Afro-Latino patients with glaucoma: 40% required secondary glaucoma surgery at 1 year. Middle East Afr J Ophthalmol. 2019;26(4):229–234. doi:10.4103/meajo.MEAJO_126_19.
   PubMed Web of Science ®Google Scholar
• Hong K, Lind J, Sheybani A. Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital. Eye Vis. 2020;7(1):5. doi:10.1186/s40662-019-0171-0.
   PubMedGoogle Scholar
• Nazarali SA, Damji KF. Ab interno trabeculectomy with Trabectome: outcomes in African American versus Caucasian patients. Can J Ophthalmol. 2018;53(4):361–364. doi:10.1016/j.jcjo.2017.10.018.
   PubMed Web of Science ®Google Scholar
• Rahmatnejad K, Pruzan NL, Amanullah S, Shaukat BA, Resende AF, Waisbourd M, Zhan T, Moster M. Surgical outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with open-angle glaucoma. J Glaucoma. 2017;26(12):1137–1143. doi:10.1097/IJG.0000000000000802.
   PubMed Web of Science ®Google Scholar
• Laroche D, Nkrumah G, Ng C. Real-world efficacy of the Hydrus microstent in Black and Afro-Latinx patients with glaucoma: a retrospective study. Ther Adv Ophthalmol. 2020;12:2515841420964311. doi:10.1177/2515841420964311.
   Web of Science ®Google Scholar
• Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25(3):316–322. doi:10.1016/s0886-3350(99)80078-9.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Peckar C, Pienaar A, Koerber N, Stegmann R. Long-term results of up to 12 years of over 700 cases of viscocanalostomy for open-angle glaucoma. Acta Ophthalmol. 2015;93(4):362–367. doi:10.1111/aos.12513.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Fraenkl S, Schoetzau A, Flammer J, Orgül S. Circumferential viscocanalostomy and suture canal distension (canaloplasty) for whites with open-angle glaucoma. J Glaucoma. 2011;20(5):298–302. doi:10.1097/IJG.0b013e3181e3d46e.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Canaloplasty for primary open-angle glaucoma: long-term outcome. Br J Ophthalmol. 2010;94(11):1478–1482. doi:10.1136/bjo.2009.163170.
   PubMed Web of Science ®Google Scholar
• Grieshaber MC, Pienaar A, Olivier J, Stegmann R. Comparing two tensioning suture sizes for 360° viscocanalostomy (canaloplasty): a randomised controlled trial. Eye. 2010;24(7):1220–1226. doi:10.1038/eye.2009.317.
   PubMed Web of Science ®Google Scholar
• Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol. 1968;66(4):673–679.
   PubMed Web of Science ®Google Scholar
• Higginbotham EJ, Ederer F, Sullivan EK, VanVeldhuisen PC, Gaasterland DE, Miller E, Vela M, Sonty S. The Advanced Glaucoma Intervention Study (AGIS): 3. Baseline characteristics of black and white patient. Ophthalmology. 1998;105(7):1137–1145.
   PubMed Web of Science ®Google Scholar
• Ederer F, Shields MB. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race: 10-year results. Evidence-Based Eye Care. 2004;5:198–200.
   Google Scholar
• Ederer F, VanVeldhuisen PC, Dally LG, Gaasterland DE, Kenneth Sullivan E, Angela Vela M, Scwartz A, Blackwell E, Miller E, Shields MB. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. Am J Ophthalmol. 2001;132(3):311–320.
   PubMed Web of Science ®Google Scholar
• Gaasterland DE, Ederer F, Sullivan EK, VanVeldhuisen PC, Vela MA, Weiss H. The Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of treatment outcomes within race: seven-year results. Ophthalmology. 1998;105:1146–1164.
   PubMed Web of Science ®Google Scholar
• Anand N, Dawda VK. A comparative study of mitomycin C and 5-fluorouracil trabeculectomy in West Africa. Middle East Afr J Ophthalmol. 2012;19(1):147–152. doi:10.4103/0974-9233.92132.
   PubMedGoogle Scholar
• Reibaldi A, Uva MG, Longo A. Nine-year follow-up of trabeculectomy with or without low-dosage mitomycin-C in primary open-angle glaucoma. Br J Ophthalmol. 2008;92(12):1666–1670. doi:10.1136/bjo.2008.140939.
   PubMed Web of Science ®Google Scholar
• Palanca-Capistrano AM, Hall J, Cantor LB, Morgan L, Hoop J, WuDunn D. Long-term outcomes of intraoperative 5-fluorouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology. 2009;116(2):185–190. doi:10.1016/j.ophtha.2008.08.009.
   PubMed Web of Science ®Google Scholar
• Lachkar Y, Leyland M, Bloom P, Migdal C. Trabeculectomy with intraoperative sponge 5-fluorouracil in Afro-Caribbeans. Br J Ophthalmol. 1997;81(7):555–558. doi:10.1136/bjo.81.7.555.
   Web of Science ®Google Scholar
• Egbert PR, Williams AS, Singh K, Dadzie P, Egbert TB. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol. 1993;116(5):612–616. doi:10.1016/S0002-9394(14)73204-0.
   PubMed Web of Science ®Google Scholar
• Yorston D, Khaw PT. A randomised trial of the effect of intraoperative 5-FU on the outcome of trabeculectomy in east Africa. Br J Ophthalmol. 2001;85(9):1028–1030. doi:10.1136/bjo.85.9.1028.
   PubMed Web of Science ®Google Scholar
• Ashaye AO, Komolafe OO. Post-operative complication of trabeculectomy in Ibadan, Nigeria: outcome of 1-year follow-up. Eye. 2009;23(2):448–452. doi:10.1038/sj.eye.6702979.
   PubMed Web of Science ®Google Scholar
• Monteiro De Barros DS, Gheith ME, Siam GA, Katz LJ. Releasable suture technique. J Glaucoma. 2008;17(5):414–421. doi:10.1097/IJG.0b013e31817d2399.
   PubMed Web of Science ®Google Scholar
• Liang YB, Feng MY, Meng HL, Fan SJ, Wang X, Xie LL, Yi P, Tang X, Wang NL, Thomas R. Early efficacy and complications of releasable sutures for trabeculectomy in primary angle-closure glaucoma: a randomized clinical trial. J Glaucoma. 2014;23(3):136–141. doi:10.1097/IJG.0b013e31826981c9.
   PubMed Web of Science ®Google Scholar
• Mwanza JCK, Kabasele PM. Trabeculectomy with and without mitomycin-C in a black African population. Eur J Ophthalmol. 2001;11(3):261–263. doi:10.1177/112067210101100308.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Pyfer M, Singh K, Gordon J, Piltz-Seymour J, Keates EU. Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. Ophthalmic Surg Lasers Imaging. 1999;30(5):367–374. doi:10.3928/1542-8877-19990501-08.
   Google Scholar
• Kim HY, Egbert PR, Singh K. Long-term comparison of primary trabeculectomy with 5-fluorouracil versus mitomycin C in West Africa. J Glaucoma. 2008;17(7):578–583.
   PubMed Web of Science ®Google Scholar
• Mielke C, Dawda VK, Anand N. Intraoperative 5-fluorouracil application during primary trabeculectomy in Nigeria: a comparative study. Eye. 2003;17(7):829–834. doi:10.1038/sj.eye.6700492.
   PubMed Web of Science ®Google Scholar
• Burch J, Achiron A. How does mitomycin C compare with 5-fluorouracil as an antimetabolite adjunct in trabeculectomy surgery for glaucoma?. In Burch J (Ed). Cochrane Clinical Answers, 2017. doi:10.1002/cca.1571.
   Google Scholar
• Cabourne E, Clarke JC, Schlottmann PG, Evans JR. Mitomycin C versus 5-fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2015;2015(11). doi:10.1002/14651858.CD006259.pub2.
   Web of Science ®Google Scholar
• Shah P, Agrawal P, Khaw PT, Shafi F, Sii F, ReGAE 7. Long-term outcomes of augmented trabeculectomy with mitomycin C in African Caribbean patients. Clin Exp Ophthalmol. 2012;40(4):176–182.
   Web of Science ®Google Scholar
• Morris DA, Peracha MO, Shin DH, Kim C, Cha SC, Kim YY. Risk factors for early filtration failure requiring suture release after primary glaucoma triple procedure with adjunctive mitomycin. Arch Ophthalmol. 1999;117(9):1149–1154. doi:10.1001/archopht.117.9.1149.
   PubMedGoogle Scholar
• Shin DH, Kim YY, Sheth N, Ren J, Shah M, Kim C, Yang K. The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure. Ophthalmology. 1998;105(4):740–745. doi:10.1016/S0161-6420(98)94032-5.
   PubMed Web of Science ®Google Scholar
• CAT-152 Trabeculectomy Study Group. Factors affecting the outcome of trabeculectomy. An analysis based on combined data from two phase III studies of an antibody to transforming growth factor β2, CAT-152. Ophthalmology. 2007;114(10):1831–1838.
   PubMed Web of Science ®Google Scholar
• Khaw P, Grehn F, Holló G, Overton B, Wilson R, Vogel R, Smith Z. A phase III study of subconjunctival human anti-transforming growth factor β2 monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology. 2007;114(10):1822–1830.
   PubMed Web of Science ®Google Scholar
• Garris W, Le C, Zurakowski D, Ayyala R. Comparison of surgical outcomes between canaloplasty and trabeculectomy with mitomycin C at 2-year follow-up: a longitudinal cohort study. Indian J Ophthalmol. 2018;66(1):66–70. doi:10.4103/ijo.IJO_543_17.
   PubMed Web of Science ®Google Scholar
• Iwao K, Inatani M, Seto T, Takihara Y, Ogata-Iwao M, Okinami S, Tanihara H. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin c in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma. 2014;23(2):88–94. doi:10.1097/IJG.0b013e3182685167.
   PubMed Web of Science ®Google Scholar
• Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma. 2002;11(3):189–196.
   PubMed Web of Science ®Google Scholar
• Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C. Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma. Can J Ophthalmol/J Can D’Ophtalmologie. 2007;42(1):89–94. doi:10.3129/can.j.ophthalmol.06-124.
   PubMed Web of Science ®Google Scholar
• Nguyen AH, Fatehi N, Romero P, Miraftabi A, Kim EAh, Morales E, Giaconi JAnn, Coleman AL, Law SK, Caprioli J, et al. Observational outcomes of initial trabeculectomy with mitomycin C in patients of African descent vs patients of European descent: five-year results. JAMA Ophthalmol. 2018;136(10):1106–1113. doi:10.1001/jamaophthalmol.2018.2897.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789–803.e2. doi:10.1016/j.ajo.2011.10.026.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Feuer WJ, Lim KS, Barton K, Goyal S, Ahmed IIK, Bradt J, Gedde S, Bannit M. Treatment outcomes in the primary tube versus trabeculectomy study after 3 years of follow-up. Ophthalmology. 2020;127(3):333–345. doi:10.1016/j.ophtha.2019.10.002.
   PubMed Web of Science ®Google Scholar
• Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J, Gedde S, Banitt M, et al. Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology. 2018;125(5):650–663. doi:10.1016/j.ophtha.2018.02.003.
   PubMed Web of Science ®Google Scholar
• Bustros YD, Fechtner R, Khouri AS. Outcomes of Ex-PRESS and trabeculectomy in a glaucoma population of African origin: one year results. J Curr Glaucoma Pract. 2017;11(2):42–47. doi:10.5005/jp-journals-10028-1221.
   PubMedGoogle Scholar
• Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Surgical complications in the tube versus trabeculectomy study during the first year of follow-up. Am J Ophthalmol. 2007;143(1):23.e2–31.e2. doi:10.1016/j.ajo.2006.07.022.
   Web of Science ®Google Scholar
• Desai MA, Gedde SJ, Feuer WJ, Shi W, Chen PP, Parrish RK. Practice preferences for glaucoma surgery: a survey of the American Glaucoma Society in 2008. Ophthalmic Surg Lasers Imaging. 2011;42(3):202–208. doi:10.3928/15428877-20110224-04.
   PubMedGoogle Scholar
• Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK. Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study. Am J Ophthalmol. 2017;176:118–126. doi:10.1016/j.ajo.2017.01.003.
   PubMed Web of Science ®Google Scholar
• Christakis PG, Tsai JC, Zurakowski D, Kalenak JW, Cantor LB, Ahmed IIK. The Ahmed versus Baerveldt study: design, baseline patient characteristics, and intraoperative complications. Ophthalmology. 2011;118(11):2172–2179. doi:10.1016/j.ophtha.2011.05.003.
   PubMed Web of Science ®Google Scholar
• Christakis PG, Kalenak JW, Zurakowski D, Tsai JC, Kammer JA, Harasymowycz PJ, Ahmed IIK. The Ahmed versus Baerveldt study: one-year treatment outcomes. Ophthalmology. 2011;118(11):2180–2189. doi:10.1016/j.ophtha.2011.05.004.
   PubMed Web of Science ®Google Scholar
• Christakis PG, Kalenak JW, Tsai JC, Zurakowski D, Kammer JA, Harasymowycz PJ, Mura JJ, Cantor LB, Ahmed IIK. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology. 2016;123(10):2093–2102. doi:10.1016/j.ophtha.2016.06.035.
   PubMed Web of Science ®Google Scholar
• Christakis PG, Tsai JC, Kalenak JW, Zurakowski D, Cantor LB, Kammer JA, Ahmed IIK. The Ahmed versus Baerveldt study: three-year treatment outcomes. Ophthalmology. 2013;120(11):2232–2240. doi:10.1016/j.ophtha.2013.04.018.
   PubMed Web of Science ®Google Scholar
• Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J. The Ahmed Baerveldt comparison study: methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology. 2011;118(3):435–442. doi:10.1016/j.ophtha.2010.07.015.
   PubMed Web of Science ®Google Scholar
• Barton K, Feuer WJ, Budenz DL, Schiffman J, Costa VP, Godfrey DG, Buys Y. Three-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2014;121(8):1547–1557.e1. doi:10.1016/j.ophtha.2014.01.036.
   PubMed Web of Science ®Google Scholar
• Budenz DL, Barton K, Gedde SJ, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys Y. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015;122(2):308–316. doi:10.1016/j.ophtha.2014.08.043.
   PubMed Web of Science ®Google Scholar
• Ishida K, Netland PA. Ahmed glaucoma valve implantation in African American and white patients. Arch Ophthalmol. 2006;124(6):800–806. doi:10.1001/archopht.124.6.800.
   PubMedGoogle Scholar
• Syed HM, Law SK, Nam SH, Li G, Caprioli J, Coleman A. Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison. J Glaucoma. 2004;13(1):38–45. doi:10.1097/00061198-200402000-00008.
   PubMed Web of Science ®Google Scholar
• Tsai JC, Johnson CC, Kammer JA, Dietrich MS. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II. Longer-term outcomes from a single surgeon. Ophthalmology. 2006;113(6):913–917. doi:10.1016/j.ophtha.2006.02.029.
   PubMed Web of Science ®Google Scholar
• WuDunn D, Phan ADT, Cantor LB, Lind JT, Cortes A, Wu B. Clinical experience with the Baerveldt 250-mm2 Glaucoma Implant. Ophthalmology. 2006;113(5):766–772. doi:10.1016/j.ophtha.2006.01.049.
   PubMed Web of Science ®Google Scholar
• Harbick KH, Sidoti PA, Budenz DL, Venkatraman A, Bruther M, Grayson DK, Ko A, Yi G. Outcomes of inferonasal Baerveldt glaucoma drainage implant surgery. J Glaucoma. 2006;15(1):7–12.
   PubMed Web of Science ®Google Scholar
• Coleman AL, Hill R, Wilson MR, Choplin N, Kotas-Neumann R, Tam M, Bacharach J, Panek W. Initial clinical experience with the Ahmed glaucoma valve implant. Am J Ophthalmol. 1995;120(1):23–31. doi:10.1016/s0002-9394(14)73755-9.
   PubMed Web of Science ®Google Scholar
• Kiage D, Gradin D, Gichuhi S, Damji K. Ahmed glaucoma valve implant: experience in East Africa. Middle East Afr J Ophthalmol. 2009;16(3):151. doi:10.4103/0974-9233.56230.
   PubMedGoogle Scholar
• Gessesse GW. The Ahmed glaucoma valve in refractory glaucoma: experiences in Southwest Ethiopia. Ethiop J Health Sci. 2015;25(3):267–272. doi:10.4314/ejhs.v25i3.10.
   PubMedGoogle Scholar
• Giorgis AT. Initial clinical experience of tube-shunt surgery in Ethiopian patients with refractory glaucoma. Ethiop Med J. 2012;50(2):159–165.
   PubMedGoogle Scholar
• Lin ZJ, Xu S, Huang SY, Zhang XB, Zhong YS. Comparison of canaloplasty and trabeculectomy for open angle glaucoma: a meta-analysis. Int J Ophthalmol. 2016;9(12):1814–1819.
   PubMed Web of Science ®Google Scholar
• HaiBo T, Xin K, ShiHeng L, Lin L. Comparison of Ahmed glaucoma valve implantation and trabeculectomy for glaucoma: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0118142. doi:10.1371/journal.pone.0118142.
   PubMed Web of Science ®Google Scholar